Biocon Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 08, 2025. Further, the company has informed the Exchange regarding voting results.
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon Limited submitted the voting results and scrutinizer's report for its 47th AGM held on August 8, 2025 via video conferencing. All 18 resolutions were approved by shareholders, with most passing with over 99% support. Key items approved include the adoption of audited financial statements for FY25, a final dividend of Rs. 0.50 per equity share (10%), re-appointment of Prof. Ravi Rasendra Mazumdar as Director and Naina Lal Kidwai as Independent Director, and multiple related-party transactions between subsidiaries. Total voting turnout was around 80.5% of outstanding shares, with promoters voting 100% in favor on every resolution. Notably, Resolution 16 (increase in investment/loan/guarantee limits) saw the highest dissent at 6.83% against, though it still passed as a special resolution.
Shareholders have approved a final dividend of Rs. 0.50 per share for FY25, which will be paid to eligible holders. The strong approval across most resolutions signals shareholder confidence in management, though the relatively higher dissent on the investment-limits resolution is worth noting. No material governance issues or rejected resolutions.